BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

CAPITAL FUND MANAGEMENT S.A.'s Holding History (CIK: 0001323645)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 51,913 Value ($000) $465 Avg Close $9.31 Range $6.02 - $11.31
Q4 2024
Shares 59,327 Value ($000) $446 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 357,615 Value ($000) $2,718 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 247,540 Value ($000) $1,530 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 211,531 Value ($000) $1,075 Avg Close $5.62 Range $4.82 - $7.75
Q3 2023
Shares 122,778 Value ($000) $869 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 169,688 Value ($000) $1,195 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 65,294 Value ($000) $545 Avg Close $9.63 Range $7.82 - $12.08
Q1 2022
Shares 117,505 Value ($000) $1,910,631 Avg Close $16.04 Range $11.56 - $19.99
Q2 2014
Shares 38,904 Value ($000) $496 Avg Close $9.73 Range $7.29 - $12.86